Barinthus Biotherapeutics plc

BRNSNASDAQ Global Market·USD·Closed

BRNSNASDAQ·USD·Closed

$0.72

+0.56%

$0.72

+$0.00 (0.56%)

52W Range

9thpctl

Volume

1.52×avg

Mkt Cap

29.57MUSD

P/E

-0.5TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

9thpctl

Volume

1.52×avg

Market Cap

29.57MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-68.7%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage-1116.7×

Current ratio6.05×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required